“…There have also been published case reports of GV treating the skin lesions of transgrediens pachyonychia congenita and hypereosinophillic syndrome . A recent study showed that topical administration of GV may be effective in treating purigo nodularis and atopic dermatitis, and further study is needed . We have found that atopic dermatitis expresses high levels of ang‐2, accounting for the vascular permeability and erythema observed in atopic dermatitis .…”
Section: Dermatitis and Other Uses In Dermatologymentioning
Gentian violet (GV) has a long and varied history as a medicinal agent. Historically used as an anti-bacterial and anti-fungal, recent reports have shown its utility as an anti-typranosomal, anti-viral and anti-angiogenic agent. The objective of this paper is to summarize evidence regarding the efficacy, and safety of GV use in dermatology. Recent discoveries have found novel targets of GV, namely NADPH oxidase in mammalian cells and thioredoxin reductase 2 in bacterial, fungal, and parasitic cells. These discoveries have expanded the use of GV in the 21st century. Given that GV is well tolerated, effective and inexpensive, its use in dermatology is predicted to increase.
“…There have also been published case reports of GV treating the skin lesions of transgrediens pachyonychia congenita and hypereosinophillic syndrome . A recent study showed that topical administration of GV may be effective in treating purigo nodularis and atopic dermatitis, and further study is needed . We have found that atopic dermatitis expresses high levels of ang‐2, accounting for the vascular permeability and erythema observed in atopic dermatitis .…”
Section: Dermatitis and Other Uses In Dermatologymentioning
Gentian violet (GV) has a long and varied history as a medicinal agent. Historically used as an anti-bacterial and anti-fungal, recent reports have shown its utility as an anti-typranosomal, anti-viral and anti-angiogenic agent. The objective of this paper is to summarize evidence regarding the efficacy, and safety of GV use in dermatology. Recent discoveries have found novel targets of GV, namely NADPH oxidase in mammalian cells and thioredoxin reductase 2 in bacterial, fungal, and parasitic cells. These discoveries have expanded the use of GV in the 21st century. Given that GV is well tolerated, effective and inexpensive, its use in dermatology is predicted to increase.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.